Christopher D. Maggiore - 28 Jul 2022 Form 4/A - Amendment Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
Director, 10%+ Owner
Signature
/s/ Christopher D. Maggiore
Issuer symbol
ZIVO
Transactions as of
28 Jul 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
08 Dec 2022, 15:17:51 UTC
Date Of Original Report
01 Aug 2022
Previous filing
16 Feb 2022
Next filing
01 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Award $0 +15,797 $0.000000 15,797 28 Jul 2022 Common stock 15,797 $3.61 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed solely to correct the date of the transaction reported to July 28, 2022.
F2 The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date.